Bwxt announces availability of fda-approved indium in-111 oxyquinoline solution

Bwx technologies, inc. announced that subsidiary bwxt itg canada, inc., having received approval from the u.s. food and drug administration (fda) on its abbreviated new drug application for its generic version of indium in-111 oxyquinoline solution, is now making the product available for sale in the united states.
BWXT Ratings Summary
BWXT Quant Ranking